Citigroup Inc. reissued their buy rating on shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in a report released on Monday, July 24th. Citigroup Inc. currently has a $1,078.00 target price on the medical equipment provider’s stock, up from their previous target price of $917.00.
Several other analysts have also recently issued reports on ISRG. Barclays PLC reissued a buy rating and issued a $800.00 price target on shares of Intuitive Surgical in a research note on Sunday, March 26th. Royal Bank Of Canada upped their price objective on shares of Intuitive Surgical from $720.00 to $770.00 and gave the stock a sector perform rating in a report on Monday, April 17th. Zacks Investment Research upgraded shares of Intuitive Surgical from a hold rating to a buy rating and set a $860.00 price objective on the stock in a report on Tuesday, April 18th. Wedbush upped their price objective on shares of Intuitive Surgical from $800.00 to $835.00 and gave the stock an outperform rating in a report on Wednesday, April 19th. Finally, Canaccord Genuity restated a buy rating and issued a $870.00 price objective (up from $800.00) on shares of Intuitive Surgical in a report on Wednesday, April 19th. Five research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the stock. The company currently has an average rating of Buy and a consensus target price of $980.61.
Shares of Intuitive Surgical (NASDAQ ISRG) opened at 984.31 on Monday. The firm has a 50-day moving average price of $946.69 and a 200-day moving average price of $844.19. Intuitive Surgical has a 52-week low of $610.71 and a 52-week high of $993.00. The stock has a market capitalization of $36.57 billion, a P/E ratio of 47.15 and a beta of 0.39. Intuitive Surgical shares are set to split on the morning of Thursday, August 31st. The 3-1 split was announced on Friday, August 11th. The newly created shares will be payable to shareholders after the closing bell on Wednesday, August 30th.
Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, July 20th. The medical equipment provider reported $5.95 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.79 by $0.16. Intuitive Surgical had a net margin of 28.44% and a return on equity of 15.99%. The company had revenue of $756.20 million during the quarter, compared to analysts’ expectations of $724.51 million. During the same quarter in the prior year, the company earned $5.62 EPS. Intuitive Surgical’s revenue was up 12.8% compared to the same quarter last year. On average, analysts predict that Intuitive Surgical will post $23.92 EPS for the current year.
In other news, VP Jamie Samath sold 242 shares of Intuitive Surgical stock in a transaction dated Tuesday, July 25th. The shares were sold at an average price of $949.01, for a total value of $229,660.42. Following the sale, the vice president now owns 23 shares of the company’s stock, valued at $21,827.23. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Amal M. Johnson sold 1,000 shares of the firm’s stock in a transaction dated Wednesday, May 31st. The shares were sold at an average price of $917.27, for a total transaction of $917,270.00. Following the completion of the sale, the director now owns 3,787 shares of the company’s stock, valued at approximately $3,473,701.49. The disclosure for this sale can be found here. In the last ninety days, insiders sold 34,065 shares of company stock worth $31,659,090. Insiders own 2.50% of the company’s stock.
Several hedge funds have recently made changes to their positions in the stock. Alps Advisors Inc. boosted its stake in shares of Intuitive Surgical by 0.3% in the second quarter. Alps Advisors Inc. now owns 647 shares of the medical equipment provider’s stock valued at $605,000 after buying an additional 2 shares during the period. Chilton Investment Co. LLC boosted its stake in shares of Intuitive Surgical by 0.4% in the second quarter. Chilton Investment Co. LLC now owns 502 shares of the medical equipment provider’s stock valued at $470,000 after buying an additional 2 shares during the period. Wilbanks Smith & Thomas Asset Management LLC boosted its position in shares of Intuitive Surgical by 0.5% in the second quarter. Wilbanks Smith & Thomas Asset Management LLC now owns 370 shares of the medical equipment provider’s stock worth $346,000 after buying an additional 2 shares during the last quarter. Guardian Life Insurance Co. of America boosted its position in shares of Intuitive Surgical by 2.2% in the first quarter. Guardian Life Insurance Co. of America now owns 142 shares of the medical equipment provider’s stock worth $109,000 after buying an additional 3 shares during the last quarter. Finally, Greenleaf Trust boosted its position in shares of Intuitive Surgical by 0.8% in the first quarter. Greenleaf Trust now owns 477 shares of the medical equipment provider’s stock worth $366,000 after buying an additional 4 shares during the last quarter. Hedge funds and other institutional investors own 96.08% of the company’s stock.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.